Department of Psychology, Carleton College, Northfield, MN, USA.
Depress Anxiety. 2017 Nov;34(11):996-1005. doi: 10.1002/da.22652. Epub 2017 May 10.
Prospective studies consistently find that smoking is a risk factor for the development of panic disorder (PD). A possible explanation is that nicotine deprivation promotes heightened sensitivity to bodily sensations and/or arterial carbon dioxide (CO ). Abrams et al. (2011) previously found that, in response to a CO rebreathing challenge, smokers experiencing more (vs. less) intense nicotine withdrawal had more severe panic symptoms and a stronger urge to escape. However, participants were aware of the last time they smoked, leaving unclear the extent to which fear reactivity was influenced by the pharmacologic effects of nicotine deprivation versus beliefs regarding when nicotine was most recently used. The present study aimed to ascertain whether nicotine deprivation, independent of beliefs regarding recent nicotine use, promotes fear reactivity among smokers.
Moderate to heavy smokers without PD (N = 25) participated in a placebo-controlled, double-blind study consisting of two sessions spaced 1 week apart. Participants abstained from nicotine for 2 hr prior to sessions. During one session participants were given a 21 mg nicotine replacement patch and, during the other, a placebo patch, with the order counterbalanced. For both sessions, after a 3-hr absorption period, participants underwent a 10-min CO rebreathing challenge.
Wearing a nicotine (vs. placebo) patch increased self-reported panic reactivity among participants, but did not significantly affect physiological and behavioral measures of reactivity.
In smokers without a history of PD, nicotine deprivation attenuates subjective panic reactivity. Possible explanations for the contrast between theory and laboratory findings as well as clinical implications are discussed.
前瞻性研究一致发现,吸烟是惊恐障碍(PD)发展的一个风险因素。一种可能的解释是,尼古丁缺乏会导致对身体感觉和/或动脉二氧化碳(CO )的敏感性增强。Abrams 等人。(2011 年)先前发现,在对 CO 再呼吸挑战的反应中,经历更(而非更少)强烈的尼古丁戒断的吸烟者出现更严重的惊恐症状和更强烈的逃避冲动。然而,参与者知道他们最后一次吸烟的时间,这使得不清楚恐惧反应在多大程度上受到尼古丁剥夺的药理学效应以及对最近使用尼古丁的时间的信念的影响。本研究旨在确定尼古丁剥夺是否会促进吸烟者的恐惧反应,而与最近使用尼古丁的信念无关。
没有 PD 的中度至重度吸烟者(N=25)参加了一项为期 1 周的安慰剂对照、双盲研究,包括两次间隔 1 周的会议。参与者在会议前 2 小时停止吸烟。在一次会议中,参与者被给予 21 毫克尼古丁替代贴片,而在另一次会议中,给予安慰剂贴片,顺序随机。对于两次会议,在 3 小时吸收期后,参与者进行了 10 分钟的 CO 再呼吸挑战。
佩戴尼古丁(而非安慰剂)贴片会增加参与者报告的惊恐反应,但对反应的生理和行为测量没有显著影响。
在没有 PD 病史的吸烟者中,尼古丁剥夺会减弱主观惊恐反应。讨论了理论与实验室发现之间的对比以及可能的临床意义的可能解释。